GPT and anemia (phenotype): The most common adverse effects of gemcitabine are symptoms in gastrointestinal, hepatic and hematopoietic disorders including nausea, vomiting, increased alanine aminotransferase (ALT) and aspartate aminotransferase (AST), increased alkaline phosphatase, anemia, and thrombocytopenia [2].